Additional file 2: of Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis
Lucilla Parnetti
Elena Chipi
Nicola Salvadori
Katia D’Andrea
Paolo Eusebi
10.6084/m9.figshare.7592414.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_of_Prevalence_and_risk_of_progression_of_preclinical_Alzheimer_s_disease_stages_a_systematic_review_and_meta-analysis/7592414
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivity. Table S3. Education years. (DOCX 53 kb)
2019-01-15 05:00:00
Preclinical Alzheimer’s disease
Systematic review
Biomarkers
National Institute on Aging–Alzheimer’s Association criteria
Prevalence